skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Rosette nanotubes show low acute pulmonary toxicity in vivo

Original Research

(3401) Views  (804) Full article downloads

Authors: W Shane Journeay, Sarabjeet S Suri, Jesus G Moralez, Hicham Fenniri, Baljit Singh

Published Date October 2008 Volume 2008:3(3) Pages 373 - 383
DOI: http://dx.doi.org/10.2147/IJN.S3489

W Shane Journeay1, Sarabjeet S Suri1, Jesus G Moralez2, Hicham Fenniri2, Baljit Singh1

1Immunology Research Group, Toxicology Graduate Program and Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, SK, S7N 5B4, Canada; 2National Institute of Nanotechnology, National Research Council (NINT-NRC) and Department of Chemistry, University of Alberta, 11421 Saskatchewan Drive, Edmonton, AB, T6G 2M9, Canada

Abstract: Nanotubes are being developed for a large variety of applications ranging from electronics to drug delivery. Common carbon nanotubes such as single-walled and multi-walled carbon nanotubes have been studied in the greatest detail but require solubilization and removal of catalytic contaminants such as metals prior to being introduced to biological systems for medical application. The present in vivo study characterizes the degree and nature of inflammation caused by a novel class of self-assembling rosette nanotubes, which are biologically inspired, naturally water-soluble and free of metal content upon synthesis. Upon pulmonary administration of this material we examined responses at 24 h and 7d post-exposure. An acute inflammatory response is triggered at 50 and 25 μg doses by 24 h post-exposure but an inflammatory response is not triggered by a 5 μg dose. Lung inflammation observed at a 50 μg dose at 24 h was resolving by 7d. This work suggests that novel nanostructures with biological design may negate toxicity concerns for biomedical applications of nanotubes. This study also demonstrates that water-soluble rosette nanotube structures represent low pulmonary toxicity, likely due to their biologically inspired design, and their self-assembled architecture.

Keywords: nanotoxicology, biocompatibility, nanomedicine, pulmonary drug delivery, lung inflammation






 

Other articles by Dr Baljit Singh



Readers of this article also read:

Biocompatibility and applications of carbon nanotubes in medical nanorobots
Cytotoxicity and reactive oxygen species generation from aggregated carbon and carbonaceous nanoparticulate materials
Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases
A generic expression system to produce proteins that co-assemble with alkane thiol SAM
Nanocrystal technology, drug delivery and clinical applications
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
The use of nanocrystalline cellulose for the binding and controlled release of drugs
Effect of dispersants of multi-walled carbon nanotubes on cellular uptake and biological responses
Elucidation mechanism of different biological responses to multi-walled carbon nanotubes using four cell lines